Abstract PR05: SY-1425 (tamibarotene), a potent and selective RARα agonist, induces changes in the transcriptional regulatory circuit of AML cells leading to differentiation
Christopher Fiore(Dana-Farber Cancer Institute), Christian Fritz(AVEO Oncology (United States)), Matthew G. Guenther(Arsenal Medical (United States)), Matthew L. Eaton(Lypro Biosciences (United States)), Michael R. McKeown(Howard Hughes Medical Institute), Mei Wei Chen(AVEO Oncology (United States)), Ravindra Majeti(Stanford University), Darren Smith(AVEO Oncology (United States)), Kathryn Austgen(AVEO Oncology (United States)), Emily Lee(Environmental Law Institute), Eric R. Olson(Vertex Pharmaceuticals (United States)), M. Ryan Corces(Gladstone Institutes)
Cited by 0
Related Papers
An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues
|Nature Methods|2017|2.8k
A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression
|Nature|2011|2k
ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis
|Nature Genetics|2021|1.5k
The chromatin accessibility landscape of primary human cancers
|Science|2018|1.4k